期刊文献+

金纳米微粒修饰几丁聚糖微胶囊新方法 被引量:2

Chemical modifications of alginate-chitosan microcapsules with gold nanoparticles
下载PDF
导出
摘要 制备了金-海藻酸钙-几丁聚糖微胶囊,提出了修饰用于蛋白质药物靶向传输的多糖载体-几丁聚糖的新方法,该方法通过在几丁聚糖微胶囊表面结合金的纳米微粒使微胶囊表面结构发生变化,从而改变微胶囊的性质,这种修饰方法目前未见报道。文中对制备条件进行了优化,并对金-海藻酸钙-几丁聚糖微胶囊的粒径分布进行了表征。文中选择在pH值为5时反应2h,制得的柠檬酸体系和丙烯酸体系的金-海藻酸钙-几丁聚糖微胶囊的平均直径分别为216.686μm和196.850μm。 A new method of modification for alginate-chitosan microcapsules with gold nanoparticles was reported. The gold-alginate-chitosan microcapsules were prepared with gold nanoparticles solutions. The optimum conditions of reactions and the particle size distributions of the gold-alginate-chitosan microcapsules were investigated. The value of pH=5.0 and reaction time of 120 minutes for reaction were chosen. The average diameters of the gold-alginate-chitosan microcapsules prepared respectively with citrate-stabilised gold nanoparticles and acrylate-stabilised gold ones were 216.686μm and 196.850 μm.
出处 《化工进展》 EI CAS CSCD 北大核心 2008年第11期1836-1840,1845,共6页 Chemical Industry and Engineering Progress
基金 英国伯明翰大学资助项目 甘肃省教育厅资助项目
关键词 微胶囊 化学修饰 金纳米微粒 金-海藻酸钙-几丁聚糖 microcapsules chemical modification gold nanoparticles gold-alginate -chitosan
  • 相关文献

参考文献16

  • 1Thanou M, Verhoef J C, Marbach P, et al. Intestinal absorption of octreotide: N-trimethyl chitosan chlorde(TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro andvivo[J].J. Pharm. Sci., 2000, 89(7): 951-957.
  • 2Aiedeh K, Taha M O. Synthesis of chitosan succinate and chitosan phthalate and their evaluation as suggested matrices in orally administered, colon-specific drug delivery systems[J]. Archivder. Pharmazie, 1999, 332(3): 103-107.
  • 3Florea B I, Thanou M, Geldof M, et al. Modified chitosan oligosaccharides as transfection agents for gene therapy of cystic fibrosis[C]//Proc. Int.Symp. Control. Release Bioact. Mater., 2000, 27.. 846-847.
  • 4Lee K Y, Kwon I C, Kim Y H, et al. Preparation of chitosan self-aggregates as a gene delivery system[J]. J. Control. Release, 1998, 51(2-3): 213-220.
  • 5Sakkinen M, Seppala U, Heinanen P, et al. In vitro evaluation of microcrystalline chitosan (MCCh) as gel-forming excipient in matrix granules[J]. Eur. J. Pharm. Biopharm., 2002, 54(1): 33-40.
  • 6Giunchedi P, Genta I, Conti B, et al. Preparation and characterization of ampicillin loaded methylpyrrolidinone chitosan and chitosan microspheres[J],Biomaterials, 1998, 19(1-3): 157-161.
  • 7Muzzarelli RAA, Baldassarre V, Conti F, et al. The biological activity of chitosan: Ultrastructural study[J]. Biomaterials, 1988, 9(3): 247-252.
  • 8Muzzarelli R A A. Depolymerization of methylpyrrolidinone chitosan by lysozyme[J]. Carbohydr. Polym., 1992, 19(11): 29-34.
  • 9Muzzarelli R A A. In vivo biochemical significance of chitin-based medical items[C]//Dumitrius, Szycher M (Eds), Polymeric Materials for Biomedical Applications, Marcel Dekker, New York, 1992: 179-198.
  • 10Chen X G, Lee C M, Park H J. O/W emulsification for the self-aggregation and nanoparticle formation of linoleic acids modified chitosan in the aqueous system[J]. J. Agric. Food Chem., 2003, 51(10): 3135-3139.

同被引文献29

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部